glutathione drug release

glutathione drug release responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology Redox-Responsive Polyprodrugs: Recent Innovations in

Name: glutathione drug release responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology Redox-Responsive Polyprodrugs: Recent Innovations in
Brand: iglepidom.org
SKU: 71912608668
Price: 20.57 USD
Availability: InStock
Rating: 4.7038 (20 reviews)

Redox Responsive Polyprodrugs: Recent Innovations in Reduction and Oxidation Responsive Drug Delivery Systems Chemistry of Materials Glutathione conjugation dose dependently increases brain specific liposomal drug delivery in vitro and in vivo ScienceDirect Nanomedicines with Versatile GSH Responsive Linkers for Cancer Theranostics ACS Biomaterials Science & Engineering Thermo glutathione sensitive release kinetics of heterogeneous magnetic micro organogel prepared by sono catalysis ScienceDirect

SKU: 71912608668 · From iglepidom.org

4.7

USD20.57 USD47.57

Pay in 4 interest-free payments of $5.14 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

Additionally, fibroblast growth factor 2 secreted by MenSCs further promotes angiogenesis and cellular proliferation, thereby attenuating ovarian fibrosis and restoring sex hormone levels (Seo et al., 2013)

(C) Real-time PCR was performed on 8226/S, 8226/S-CR, 8226/S-ATOR05 cells, as well as 8226/S-ATOR05 cells cultured in the absence of ATO for 7, 14, 21, 35, and 50 days to determine the expression patterns of Bfl-1